$3.55
6.08% yesterday
Nasdaq, Oct 09, 10:06 pm CET
ISIN
US67113Y1082
Symbol
NUWE

Nuwellis Inc Stock price

$3.55
-0.79 18.20% 1M
-32.57 90.17% 6M
-43.07 92.39% YTD
-63.23 94.68% 1Y
-63,206.45 99.99% 3Y
-1,494,986.45 100.00% 5Y
-98,722,259,996.45 100.00% 10Y
-444,379,823,996.45 100.00% 20Y
Nasdaq, Closing price Thu, Oct 09 2025
-0.23 6.08%

Key metrics

Basic
Market capitalization
$3.2m
Enterprise Value
$-1.3m
Net debt
positive
Cash
$4.5m
Shares outstanding
10.0k
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.4 | 0.3
EV/Sales
negative | negative
EV/FCF
0.1
P/B
negative
Financial Health
Equity Ratio
66.2%
Return on Equity
-162.7%
ROCE
-169.2%
ROIC
-538.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$8.3m | $9.3m
EBITDA
$-8.7m | -
EBIT
$-9.0m | $-8.6m
Net Income
$-14.7m | $-20.0k
Free Cash Flow
$-8.6m
Growth (TTM | estimate)
Revenue
-7.7% | 6.5%
EBITDA
35.5% | -
EBIT
35.0% | 21.7%
Net Income
35.6% | 99.8%
Free Cash Flow
30.1%
Margin (TTM | estimate)
Gross
60.5%
EBITDA
-104.6% | -
EBIT
-108.0%
Net
-176.4% | -0.2%
Free Cash Flow
-103.6%
More
EPS
$-2,994.9
FCF per Share
$-861.9
Short interest
6.1%
Employees
38
Rev per Employee
$230.0k
Show more

Is Nuwellis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,998 stocks worldwide.

Nuwellis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Nuwellis Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Nuwellis Inc forecast:

Buy
86%
Hold
14%

Financial data from Nuwellis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
8.32 8.32
8% 8%
100%
- Direct Costs 3.28 3.28
8% 8%
39%
5.04 5.04
7% 7%
61%
- Selling and Administrative Expenses 12 12
17% 17%
149%
- Research and Development Expense 2.54 2.54
42% 42%
31%
-8.70 -8.70
35% 35%
-105%
- Depreciation and Amortization 0.28 0.28
18% 18%
3%
EBIT (Operating Income) EBIT -8.99 -8.99
35% 35%
-108%
Net Profit -15 -15
36% 36%
-176%

In millions USD.

Don't miss a Thing! We will send you all news about Nuwellis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuwellis Inc Stock News

Neutral
GlobeNewsWire
10 days ago
ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a population with extremely limited treatment options Results highlight life-threatening gaps in pediatric care and underscore Nuwellis' commitment to pediatric innovation and integrated cardio-renal care MINNEAPOLIS, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Nuwellis...
Neutral
GlobeNewsWire
22 days ago
EDEN PRAIRIE, Minn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No.
Neutral
GlobeNewsWire
23 days ago
Watch the “What This Means” segment here
More Nuwellis Inc News

Company Profile

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Head office United States
CEO John Erb
Employees 38
Founded 1999
Website www.nuwellis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today